On Wednesday, Shares of Baxalta Inc (NYSE:BXLT), gained 3.10% to $35.63.
Baxalta Incorporated, declared that the European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP) has offered a positive opinion, licensing European production of HYQVIA [Immune Globulin Infusion 10% (Human) with Recombinant Human Hyaluronidase] and GAMMAGARD LIQUID 10% [Immune Globulin Infusion (Human)] (marketed as KIOVIG in the EU)* through Baxalta’s manufacturing services agreement with Stichting Sanquin Bloedvoorziening (Sanquin Blood Supply Foundation or Sanquin) in the Netherlands. Both products are indicated to treat specific types of patients with primary immune deficiency.
Baxalta continues to optimize its manufacturing network to support increasing global demand for plasma–based therapies. The positive opinion from CHMP allows Sanquin to process plasma supplied by Baxalta into bulk material for HYQVIA and GAMMAGARD LIQUID 10% in the European markets. These additional manufacturing capabilities also allow Baxalta to optimize capacity at other facilities to serve other regions. Baxalta will continue to supply the U.S. market from its U.S. Food and Drug Administration (FDA) approved manufacturing sites in the U.S., Austria and Italy.
“Meeting the increasing demand for plasma-based therapies is a key component of our global manufacturing strategy,” said John Furey, senior vice president and head of Global Operations, Baxalta. “This CHMP positive opinion enables Baxalta to provide additional supply of critical plasma-based therapies by leveraging our manufacturing network and regional partners to optimize our flexibility and capacity.”
Baxalta Incorporated, a biopharmaceutical company, develops, manufactures, and markets a portfolio of products primarily for the treatment of hematology and immunology worldwide. It also offers other therapies for the treatments of bleeding disorders, and chronic and acute medical conditions, counting hemophilia A, hemophilia B, attained hemophilia, inhibitor treatments, primary immunodeficiency (PID), and alpha-1 antitrypsin deficiency.
Shares of Manulife Financial Corporation (USA) (NYSE:MFC), inclined 0.18% to $16.82, during its last trading session.
John Hancock Financial is a division of Manulife Financial, a leading Canada-based financial services group with principal operations in Asia, Canada and the United States.
John Hancock Income Securities Trust (JHS), John Hancock Investors Trust (JHI), John Hancock Premium Dividend Fund (PDT), and John Hancock Tax-Advantaged Dividend Income Fund (HTD) (each the “Fund” and collectively, the “Funds”), closed-end funds that utilize leverage, declared a new liquidity facility provider.
Effective December 2, 2015, each Fund has reached a new liquidity facility agreement with State Street Bank and Trust Company, a partner of State Street Corporation (“State Street”). The new liquidity facility agreements replace the credit facility agreements with the previous facility provider.
Manulife Financial Corporation, together with its auxiliaries, provides financial protection and wealth administration products and services to individual, corporate, and business customers primarily in Asia, Canada, and the United States. It offers various individual life and health insurance, and individual and group long-term care insurance products through insurance agents, brokers, banks, financial planners, and direct marketing.
Finally, Shares of Master card Inc (NYSE:MA), ended its last trade with -0.84% loss, and closed at $97.11.
RentMoola, North America’s most innovative and fasting growing online rent payment service focused on disrupting the traditional pay-rent-by-cheque approach used by most North Americans, declared it would position MasterCard as its preferred payment brand on RentMoola’s payment network in the U.S. and Canada . The agreement provides tenants and condo owners a preferred rate for all MasterCard credit and debit card payments in addition to rewards with exclusive offers when paying with MasterCard-branded cards on RentMoola. In addition, Rent Moola will offer users the ability to pay with Master Pass by MasterCard in early 2016.
Master Pass enables consumers to pay for the things they want with the security they demand, anywhere online or in-app, using any device. Master Pass securely stores shoppers’ preferred payment information, which is readily accessible when they check out. Once live with RentMoola, MasterPass will give tenants the option to simply select “Buy with Master Pass,” sign into their wallet, select their desired payment option and then confirm the rent payment.
Patrick Postrehovsky, CEO & Co-Founder said, “We are happy to partner with MasterCard and offer our tenants the ability to make paying their rent rewarding and frictionless by leveraging their rewards programs when paying rent. MasterCard and Rent Moola share the belief that consumers want choice and rewards, something checks/cheques and other payment methods do not offer. MasterCard is a valued partner in our business and we look forward to additional partnership opportunities that offer raised value to MasterCard cardholders.”
MasterCard Incorporated, a technology company, provides transaction processing and other payment-related products and services in the United States and internationally. The company facilitates the processing of payment transactions, counting authorization, clearing, and settlement, in addition to delivers related products and services.